Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.09 billion.
Market Cap
1.3T
Revenue
115.09B
Profits
-39.17B
PE Ratio
n/a
Profit Margin
-34.03%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 134.25B | 1.10% | 1,065,448 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.58B | -1.37% | 939,190 | 15.53B |
| 3 | ARGX | argenx SE | 54.05B | -0.16% | 476,354 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 44.06B | -0.69% | 1,681,002 | - |
| 5 | ONC | BeOne Medicines AG | 40.85B | 0.08% | 634,929 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.23B | -0.31% | 2,394,338 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.60B | 1.94% | 1,438,184 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.95B | -1.62% | 2,728,712 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.46B | -1.48% | 5,841,828 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.54B | -0.39% | 1,080,065 | 5.82B |
| 11 | MRNA | Moderna, Inc. | 24.18B | 1.27% | 6,556,327 | 2.23B |
| 12 | BNTX | BioNTech SE | 23.31B | - | 705,980 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.37B | -0.06% | 1,587,052 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.78B | -0.41% | 418,491 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.36B | -1.15% | 3,082,130 | 713.07M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.10B | -3.33% | 1,288,298 | 4.60B |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.46B | 0.97% | 3,966,159 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 12.72B | -3.08% | 2,038,686 | 2.44B |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.61B | 1.03% | 1,042,511 | 669.50M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | 3.87% | 415,197 | 1.28B |
| 21 | CORT | Corcept Therapeutics Incorporated | 12.09B | -2.07% | 699,951 | 830.81M |
| 22 | SMMT | Summit Therapeutics Inc. | 12.06B | 1.65% | 4,960,448 | - |
| 23 | HALO | Halozyme Therapeutics, Inc. | 11.65B | - | 2,846,032 | 1.66B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.30B | -2.32% | 834,377 | 776.57M |
| 25 | TECH | Bio-Techne Corporation | 11.24B | 0.04% | 3,264,226 | 1.22B |
| 26 | ABVX | ABIVAX Société Anonyme | 10.94B | -0.54% | 466,237 | 5.67M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.63B | -1.34% | 1,270,142 | 67.67M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.35B | 1.01% | 320,981 | 7.46M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.11B | 0.03% | 1,060,418 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 9.68B | -1.37% | 147,902 | 440.48M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.60B | -1.14% | 306,573 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.21B | -2.67% | 2,407,129 | 874.09M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 9.11B | 0.96% | 2,380,151 | 105.00M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.06B | -2.46% | 931,735 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.95B | 0.25% | 1,422,042 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.81B | 1.60% | 796,777 | - |
| 37 | IMVT | Immunovant, Inc. | 8.45B | 2.61% | 1,138,925 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.05B | 1.47% | 5,033,049 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.77B | -2.28% | 728,856 | 239.92M |
| 40 | TGTX | TG Therapeutics, Inc. | 7.08B | 1.51% | 1,500,779 | 799.54M |
| 41 | BLTE | Belite Bio, Inc | 6.99B | 6.17% | 237,868 | - |
| 42 | ORKA | Oruka Therapeutics, Inc. | 6.93B | -0.44% | 812,283 | - |
| 43 | CGON | CG Oncology, Inc. | 6.83B | 0.61% | 809,612 | 6.23M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.72B | -6.81% | 2,781,612 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 6.54B | -1.11% | 6,044,005 | 989.61M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -0.48% | 579,016 | 618.07M |
| 47 | ERAS | Erasca, Inc. | 6.36B | 1.05% | 3,426,210 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.35% | 853,904 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 6.15B | -1.25% | 763,595 | 1.01B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | -1.57% | 665,646 | 7.50M |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 6.07B | -2.96% | 778,224 | 1.90M |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 5.76B | -2.35% | 368,556 | 290.54M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.68B | -1.12% | 1,282,790 | 591.33M |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.50B | -9.39% | 3,362,229 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 5.23B | 1.05% | 1,066,371 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.07B | 0.07% | 1,346,524 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.99B | 0.79% | 1,399,121 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | -0.61% | 1,088,178 | - |
| 59 | PBLS | Parabilis Medicines, Inc. | 4.64B | 2.07% | 333,231 | - |
| 60 | MANE | Veradermics, Incorporated | 4.55B | -1.63% | 561,903 | - |
| 61 | TNGX | Tango Therapeutics, Inc. | 4.44B | -4.81% | 2,260,809 | 53.81M |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.38B | 0.25% | 1,976,993 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.31B | -1.08% | 1,277,497 | - |
| 64 | CELC | Celcuity Inc. | 4.30B | -2.95% | 619,399 | - |
| 65 | LEGN | Legend Biotech Corporation | 4.22B | 5.66% | 4,231,795 | 1.27B |
| 66 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.78% | 81,751 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.95B | -1.24% | 1,145,289 | 3.60M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.94B | -1.86% | 1,011,662 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.72B | -3.12% | 471,769 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.66B | 0.07% | 766,892 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | 0.27% | 488,602 | 234.13M |
| 72 | CLDX | Celldex Therapeutics, Inc. | 3.48B | 3.16% | 767,368 | 158.00K |
| 73 | NAMS | NewAmsterdam Pharma Company N.V. | 3.30B | -1.29% | 2,343,326 | 7.12M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | 1.20% | 1,050,004 | 463.98M |
| 75 | ALMS | Alumis Inc. | 3.23B | -7.85% | 1,324,327 | 8.40M |
| 76 | MBX | MBX Biosciences, Inc. | 3.18B | -0.21% | 359,758 | - |
| 77 | QURE | uniQure N.V. | 3.12B | -2.30% | 984,427 | 18.67M |
| 78 | IRON | Disc Medicine, Inc. | 3.12B | 3.74% | 254,558 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 3.05B | 2.51% | 740,801 | 606.33M |
| 80 | ABCL | AbCellera Biologics Inc. | 2.99B | 4.50% | 18,371,187 | 66.17M |
| 81 | IMNM | Immunome, Inc. | 2.97B | 2.18% | 886,892 | 4.02M |
| 82 | IOVA | Iovance Biotherapeutics, Inc. | 2.94B | 1.41% | 10,381,002 | 324.97M |
| 83 | ZLAB | Zai Lab Limited | 2.92B | 10.31% | 3,809,572 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 0.31% | 700,357 | 36.77M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.68B | -1.58% | 1,329,407 | 156.04M |
| 86 | ATAI | AtaiBeckley Inc. | 2.67B | -0.55% | 3,667,428 | 4.47M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.65B | 0.60% | 2,138,831 | 717.00M |
| 88 | KOD | Kodiak Sciences Inc. | 2.63B | -2.97% | 515,918 | - |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.60B | -0.39% | 3,062,963 | 71.13M |
| 90 | NKTR | Nektar Therapeutics | 2.55B | 0.85% | 325,860 | 55.63M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 2.54B | - | 1,322,184 | - |
| 92 | PGEN | Precigen, Inc. | 2.46B | -2.00% | 4,876,243 | 85.72M |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.44B | -0.58% | 231,133 | - |
| 94 | COAG | Hemab Therapeutics Holdings, Inc. | 2.42B | 3.75% | 251,794 | - |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -0.18% | 679,796 | - |
| 96 | PHVS | Pharvaris N.V. | 2.41B | -1.21% | 477,250 | - |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 3.92% | 425,322 | 20.00M |
| 98 | URGN | UroGen Pharma Ltd. | 2.30B | 1.73% | 876,585 | 188.73M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | 1.33% | 557,488 | 959.90M |
| 100 | VCEL | Vericel Corporation | 2.27B | 0.91% | 416,861 | 306.30M |
| 101 | NUVB | Nuvation Bio Inc. | 2.24B | -3.48% | 4,125,010 | 169.90M |
| 102 | SEPN | Septerna, Inc. | 2.23B | 22.93% | 1,159,568 | 98.88M |
| 103 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 1.37% | 188,407 | - |
| 104 | ADMA | ADMA Biologics, Inc. | 2.22B | 1.59% | 2,538,537 | 512.28M |
| 105 | MESO | Mesoblast Limited | 2.20B | 1.44% | 143,670 | 65.38M |
| 106 | BHVN | Biohaven Ltd. | 2.19B | -0.34% | 2,362,956 | - |
| 107 | VERA | Vera Therapeutics, Inc. | 2.18B | -4.08% | 1,915,923 | - |
| 108 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | 0.09% | 4,723,060 | - |
| 109 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 5.63% | 2,180,219 | 52.06M |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 2.14B | 4.87% | 4,986,847 | 5.49M |
| 111 | STOK | Stoke Therapeutics, Inc. | 2.13B | 2.26% | 1,308,750 | 27.59M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 1.41% | 1,071,547 | 10.00M |
| 113 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -0.52% | 730,725 | 311.51M |
| 114 | GHRS | GH Research PLC | 2.00B | -1.52% | 673,371 | - |
| 115 | KARD | Kardigan, Inc. | 1.97B | 4.65% | 293,919 | - |
| 116 | NBTX | Nanobiotix S.A. | 1.95B | 7.02% | 112,080 | 38.27M |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.31% | 938,748 | 98.34M |
| 118 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 6.05% | 3,002,762 | 1.97B |
| 119 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.07% | 1,052,519 | - |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.87B | 2.78% | 234,884 | - |
| 121 | FTRE | Fortrea Holdings Inc. | 1.86B | 2.79% | 869,372 | 2.68B |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 6.76% | 492,363 | 1.13B |
| 123 | GENB | Generate Biomedicines, Inc. | 1.83B | -3.06% | 443,901 | 26.48M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -0.39% | 790,972 | 252.25M |
| 125 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | 1.82% | 11,008,328 | 54.86M |
| 126 | IMCR | Immunocore Holdings plc | 1.76B | 0.59% | 283,531 | 430.78M |
| 127 | ZYME | Zymeworks Inc. | 1.73B | 0.66% | 461,236 | 37.13M |
| 128 | ANAB | AnaptysBio, Inc. | 1.71B | 4.33% | 372,049 | 232.39M |
| 129 | AAPG | Ascentage Pharma Group International | 1.71B | 0.64% | 3,279 | 82.08M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.68B | - | 2,569,331 | 59.51M |
| 131 | XNCR | Xencor, Inc. | 1.64B | 2.41% | 1,109,982 | 104.97M |
| 132 | TRAX | First Tracks Biotherapeutics, Inc. | 1.63B | -2.44% | 613,567 | - |
| 133 | BRVE | Braveheart Bio, Inc. | 1.60B | -9.15% | 724,662 | - |
| 134 | ABSI | Absci Corporation | 1.59B | 4.44% | 2,881,007 | 1.56M |
| 135 | AVLN | Avalyn Pharma Inc. | 1.57B | 2.60% | 219,807 | - |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.56B | -14.32% | 1,716,284 | - |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.51B | 0.11% | 379,879 | 20.00M |
| 138 | VIR | Vir Biotechnology, Inc. | 1.51B | 0.45% | 1,203,156 | 303.23M |
| 139 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.51B | -4.28% | 2,424,129 | 208.78M |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.50B | -4.08% | 730,129 | - |
| 141 | INVA | Innoviva, Inc. | 1.50B | 0.34% | 596,037 | 440.00M |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.46B | -1.13% | 235,758 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 1.29% | 453,366 | - |
| 144 | OBX | Obsidian Therapeutics, Inc. | 1.43B | -6.00% | 89,940 | - |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.42B | 0.81% | 1,020,177 | - |
| 146 | JBIO | Jade Biosciences, Inc. | 1.42B | 2.85% | 525,650 | - |
| 147 | SVRA | Savara Inc. | 1.41B | -2.79% | 1,263,991 | - |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.41B | -4.27% | 3,606,585 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.40B | 0.94% | 646,967 | - |
| 150 | AKTS | Aktis Oncology, Inc. | 1.37B | 2.78% | 209,236 | 8.28M |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -0.78% | 260,026 | 1.30M |
| 152 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | -0.38% | 704,412 | 28.73M |
| 153 | IMTX | Immatics N.V. | 1.33B | 0.31% | 264,410 | 43.00M |
| 154 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 4.93% | 882,981 | - |
| 155 | NVAX | Novavax, Inc. | 1.31B | 0.76% | 2,607,367 | 413.80M |
| 156 | REPL | Replimune Group, Inc. | 1.28B | -0.15% | 4,767,047 | - |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | 7.39% | 808,168 | - |
| 158 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 1.48% | 103,464 | - |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 7.21% | 834,533 | - |
| 160 | MNKD | MannKind Corporation | 1.23B | -2.29% | 4,497,586 | 393.63M |
| 161 | MGTX | MeiraGTx Holdings plc | 1.21B | 0.23% | 288,628 | 79.76M |
| 162 | LTGO | Latigo Biotherapeutics, Inc. | 1.17B | -0.22% | 237,917 | - |
| 163 | SANA | Sana Biotechnology, Inc. | 1.13B | 4.99% | 2,520,216 | - |
| 164 | EYPT | EyePoint, Inc. | 1.13B | -0.15% | 2,058,474 | 2.79M |
| 165 | ANRO | Alto Neuroscience, Inc. | 1.12B | 1.73% | 228,524 | - |
| 166 | IVA | Inventiva S.A. | 1.12B | -0.63% | 382,924 | 7.94M |
| 167 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.25% | 3,031,985 | 41.47M |
| 168 | GERN | Geron Corporation | 1.05B | 10.14% | 12,716,754 | 204.56M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -1.52% | 714,966 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 1.01B | 0.67% | 577,863 | 24.00M |
| 171 | WVE | Wave Life Sciences Ltd. | 994.11M | -16.89% | 6,918,054 | 65.37M |
| 172 | APMD | Apnimed, Inc. | 990.40M | -10.99% | 174,735 | 120.15M |
| 173 | OMER | Omeros Corporation | 984.30M | -0.15% | 1,888,089 | 9.89M |
| 174 | ARDX | Ardelyx, Inc. | 981.80M | -1.50% | 8,166,588 | 450.89M |
| 175 | ODTX | Odyssey Therapeutics, Inc. | 975.14M | -8.21% | 107,746 | 99.00K |
| 176 | SLDB | Solid Biosciences Inc. | 948.94M | 3.39% | 900,476 | - |
| 177 | ABUS | Arbutus Biopharma Corporation | 922.50M | 1.74% | 1,047,787 | 191.45M |
| 178 | DSGN | Design Therapeutics, Inc. | 914.94M | 2.02% | 313,444 | - |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -12.65% | 2,671,325 | - |
| 180 | KURA | Kura Oncology, Inc. | 881.53M | 0.81% | 876,706 | 71.64M |
| 181 | TBPH | Theravance Biopharma, Inc. | 878.47M | 0.06% | 952,371 | 104.31M |
| 182 | ANNX | Annexon, Inc. | 874.92M | -0.93% | 924,796 | - |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 871.42M | 0.34% | 1,210,254 | 8.22M |
| 184 | DBVT | DBV Technologies S.A. | 834.54M | -1.26% | 376,363 | 5.04M |
| 185 | AURA | Aura Biosciences, Inc. | 833.79M | 4.42% | 1,008,534 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 831.18M | -1.23% | 64,993 | - |
| 187 | IMMX | Immix Biopharma, Inc. | 821.99M | 13.43% | 1,821,327 | - |
| 188 | ATTO | Attovia Therapeutics, Inc. | 802.49M | -6.00% | 475,620 | 1.35M |
| 189 | PHAR | Pharming Group N.V. | 799.42M | 7.75% | 89,776 | 366.48M |
| 190 | CLYM | Climb Bio, Inc. | 795.49M | 2.29% | 707,196 | - |
| 191 | DRUG | Bright Minds Biosciences Inc. | 792.01M | -0.67% | 350,380 | - |
| 192 | OCS | Oculis Holding AG | 787.08M | -0.08% | 143,125 | 1.45M |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 784.93M | 0.86% | 208,358 | 276.79M |
| 194 | CADL | Candel Therapeutics, Inc. | 780.33M | 1.43% | 857,173 | - |
| 195 | FTH | Faeth Therapeutics, Inc. | 775.21M | 5.01% | 217,445 | - |
| 196 | MNPR | Monopar Therapeutics Inc. | 766.74M | -1.62% | 210,762 | - |
| 197 | CTMX | CytomX Therapeutics, Inc. | 751.75M | 0.29% | 1,698,608 | 18.30M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 736.99M | -0.86% | 202,033 | - |
| 199 | ALLO | Allogene Therapeutics, Inc. | 731.73M | 0.95% | 4,967,299 | 22.00K |
| 200 | AGMB | AgomAb Therapeutics NV | 731.33M | -1.00% | 60,988 | - |
| 201 | CBIO | Crescent Biopharma, Inc. | 714.35M | -3.69% | 96,604 | 11.88M |
| 202 | NGNE | Neurogene Inc. | 713.38M | -2.05% | 352,607 | 925.00K |
| 203 | GYRE | Gyre Therapeutics, Inc. | 704.06M | -1.19% | 50,219 | 109.82M |
| 204 | RGNX | REGENXBIO Inc. | 703.04M | 2.21% | 881,200 | 174.48M |
| 205 | SLN | Silence Therapeutics plc | 695.28M | -4.60% | 3,289,355 | 615.00K |
| 206 | ACHV | Achieve Life Sciences, Inc. | 695.00M | 1.50% | 1,897,590 | - |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 675.95M | -0.70% | 1,787,261 | 239.66M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 673.41M | -1.22% | 710,556 | 136.07M |
| 209 | VSTM | Verastem, Inc. | 638.47M | 3.83% | 2,087,690 | 87.53M |
| 210 | NVCT | Nuvectis Pharma, Inc. | 632.41M | 2.81% | 166,242 | - |
| 211 | MDXG | MiMedx Group, Inc. | 629.69M | 1.17% | 1,228,726 | 355.17M |
| 212 | HELP | Cybin Inc. | 625.42M | 0.80% | 988,041 | - |
| 213 | TECX | Tectonic Therapeutic, Inc. | 623.04M | -2.57% | 162,585 | - |
| 214 | AUTL | Autolus Therapeutics plc | 620.11M | 12.56% | 7,686,269 | 117.39M |
| 215 | FDMT | 4D Molecular Therapeutics, Inc. | 599.61M | 2.96% | 453,665 | 88.24M |
| 216 | SGMT | Sagimet Biosciences Inc. | 591.75M | -0.52% | 1,480,438 | - |
| 217 | SPRY | ARS Pharmaceuticals, Inc. | 590.85M | 0.68% | 1,351,810 | 98.99M |
| 218 | ARVN | Arvinas, Inc. | 587.82M | - | 572,103 | 316.70M |
| 219 | ALT | Altimmune, Inc. | 583.42M | -1.64% | 3,634,640 | 36.00K |
| 220 | PRME | Prime Medicine, Inc. | 579.97M | 3.49% | 2,258,048 | 4.07M |
| 221 | ARTV | Artiva Biotherapeutics, Inc. | 575.93M | 4.99% | 456,610 | 251.00K |
| 222 | CRMD | CorMedix Inc. | 572.70M | -3.05% | 1,182,274 | 400.05M |
| 223 | CTNM | Contineum Therapeutics, Inc. | 557.55M | 2.28% | 903,224 | - |
| 224 | EIKN | Eikon Therapeutics, Inc. | 553.84M | 5.14% | 502,390 | - |
| 225 | STTK | Shattuck Labs, Inc. | 550.57M | 0.56% | 1,906,360 | 1.00M |
| 226 | PRLD | Prelude Therapeutics Incorporated | 547.93M | 10.14% | 698,441 | 22.42M |
| 227 | MPLT | MapLight Therapeutics, Inc. | 543.24M | -1.64% | 359,205 | - |
| 228 | VALN | Valneva SE | 542.72M | 5.47% | 99,033 | 180.25M |
| 229 | ZURA | Zura Bio Limited | 532.81M | -1.24% | 1,598,655 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 524.97M | 1.98% | 213,415 | 71.10M |
| 231 | ANL | Adlai Nortye Ltd. | 523.20M | -1.13% | 134,800 | 5.00M |
| 232 | ENTX | Entera Bio Ltd. | 519.43M | -1.32% | 487,986 | 42.00K |
| 233 | EVMN | Evommune, Inc. | 515.71M | 1.00% | 380,270 | 10.00M |
| 234 | BLSM | BlossomHill Therapeutics, Inc. | 506.23M | 3.31% | 328,472 | - |
| 235 | DNA | Ginkgo Bioworks Holdings, Inc. | 505.73M | -1.83% | 1,348,492 | 132.42M |
| 236 | OABI | OmniAb, Inc. | 491.42M | -0.29% | 1,191,344 | 38.46M |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 487.58M | 1.65% | 657,730 | - |
| 238 | PROK | ProKidney Corp. | 486.74M | -4.73% | 2,799,545 | 818.00K |
| 239 | RZLT | Rezolute, Inc. | 482.64M | -1.28% | 641,978 | - |
| 240 | OVID | Ovid Therapeutics Inc. | 481.53M | -1.53% | 903,203 | 7.12M |
| 241 | IKT | Inhibikase Therapeutics, Inc. | 478.78M | -0.41% | 580,836 | 1.00 |
| 242 | RLMD | Relmada Therapeutics, Inc. | 476.81M | -1.54% | 2,140,758 | - |
| 243 | PRTA | Prothena Corporation plc | 473.33M | 1.10% | 475,253 | 54.53M |
| 244 | OCGN | Ocugen, Inc. | 464.58M | 4.58% | 2,471,408 | 4.58M |
| 245 | BNTC | Benitec Biopharma Inc. | 463.10M | -2.18% | 53,606 | - |
| 246 | QTTB | Q32 Bio Inc. | 458.75M | -1.66% | 614,794 | 53.74M |
| 247 | CABA | Cabaletta Bio, Inc. | 454.92M | -0.36% | 3,526,694 | - |
| 248 | EDIT | Editas Medicine, Inc. | 453.06M | 4.98% | 1,910,929 | 47.01M |
| 249 | PBYI | Puma Biotechnology, Inc. | 452.71M | 0.92% | 314,597 | 231.24M |
| 250 | LRMR | Larimar Therapeutics, Inc. | 449.89M | 7.48% | 1,655,942 | - |
| 251 | FENC | Fennec Pharmaceuticals Inc. | 447.73M | 16.82% | 720,035 | 59.22M |
| 252 | SCTX | Scribe Therapeutics Inc. | 442.18M | -5.98% | 51,104 | 36.28M |
| 253 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.49M | 0.60% | 181,022 | - |
| 254 | SLBT | SL Science Holding Limited | 431.54M | -5.65% | 45,927 | 3.27M |
| 255 | CCCC | C4 Therapeutics, Inc. | 427.90M | 6.91% | 3,085,427 | 35.04M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 424.35M | 0.71% | 1,079,917 | 15.85M |
| 257 | ABEO | Abeona Therapeutics Inc. | 421.76M | -0.67% | 2,190,654 | 14.54M |
| 258 | STRO | Sutro Biopharma, Inc. | 414.92M | -1.92% | 101,626 | 99.61M |
| 259 | VTVT | vTv Therapeutics Inc. | 410.52M | -3.65% | 170,845 | 36.84M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 404.14M | 0.60% | 178,474 | - |
| 261 | CMPX | Compass Therapeutics, Inc. | 396.19M | -0.90% | 3,984,649 | 850.00K |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 393.14M | -2.10% | 200,171 | 65.26M |
| 263 | FHTX | Foghorn Therapeutics Inc. | 391.35M | 5.61% | 383,571 | 36.74M |
| 264 | UPB | Upstream Bio, Inc. | 385.84M | -4.70% | 628,056 | 3.16M |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 384.21M | -3.85% | 1,697,550 | - |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 375.33M | 3.24% | 1,332,477 | - |
| 267 | PALI | Palisade Bio, Inc. | 372.94M | 1.90% | 1,245,675 | 500.00K |
| 268 | IPSC | Century Therapeutics, Inc. | 371.53M | 4.04% | 522,837 | 109.16M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 370.47M | 3.31% | 176,298 | - |
| 270 | LYEL | Lyell Immunopharma, Inc. | 364.64M | 3.84% | 134,518 | 27.00K |
| 271 | SABS | SAB Biotherapeutics, Inc. | 342.11M | -0.53% | 312,038 | 114.70K |
| 272 | VCRE | Vicore Pharma Holding AB (publ) | 339.16M | 3.19% | - | 370.61K |
| 273 | CUVL | Clinuvel Pharmaceuticals Limited | 338.23M | 1.78% | 2,955 | 64.24M |
| 274 | AVXL | Anavex Life Sciences Corp. | 325.28M | 3.54% | 662,618 | - |
| 275 | IRD | Opus Genetics, Inc. | 322.80M | 6.01% | 538,402 | 9.86M |
| 276 | FATE | Fate Therapeutics, Inc. | 319.37M | -0.72% | 1,283,221 | 6.32M |
| 277 | NMRA | Neumora Therapeutics, Inc. | 314.98M | 4.94% | 517,500 | - |
| 278 | IMRX | Immuneering Corporation | 310.55M | 5.96% | 1,065,404 | - |
| 279 | AGEN | Agenus Inc. | 307.49M | -2.43% | 1,373,566 | 132.69M |
| 280 | TTRX | Turn Therapeutics Inc. | 304.43M | 6.46% | 66,408 | - |
| 281 | VNDA | Vanda Pharmaceuticals Inc. | 298.08M | -1.79% | 1,065,492 | 215.72M |
| 282 | IFRX | InflaRx N.V. | 294.74M | 2.04% | 491,391 | -11.54K |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 294.57M | -0.96% | 401,838 | 26.87M |
| 284 | SRZN | Surrozen, Inc. | 294.43M | -0.16% | 141,969 | 11.51M |
| 285 | ELDN | Eledon Pharmaceuticals, Inc. | 289.88M | 1.90% | 724,052 | - |
| 286 | BCYC | Bicycle Therapeutics plc | 288.37M | 0.24% | 107,224 | 61.21M |
| 287 | LCTX | Lineage Cell Therapeutics, Inc. | 283.26M | -0.88% | 763,808 | 13.08M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 281.54M | -1.60% | 804,120 | 80.00M |
| 289 | PRQR | ProQR Therapeutics N.V. | 270.95M | 6.08% | 585,701 | 15.73M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 266.87M | -6.31% | 620,476 | - |
| 291 | WHWK | Whitehawk Therapeutics, Inc. | 266.23M | 2.64% | 871,764 | 7.15M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 264.46M | -1.35% | 345,487 | 31.98M |
| 293 | RNAC | Cartesian Therapeutics, Inc. | 259.74M | -2.00% | 74,762 | 1.48M |
| 294 | ADAG | Adagene Inc. | 257.02M | -4.42% | 276,404 | 7.67M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 254.72M | -8.05% | 49,834 | 18.47M |
| 296 | TRDA | Entrada Therapeutics, Inc. | 253.84M | 1.29% | 264,102 | 4.69M |
| 297 | ACIU | AC Immune SA | 252.54M | 11.40% | 1,057,123 | 21.67M |
| 298 | MGNX | MacroGenics, Inc. | 249.17M | -3.92% | 479,237 | 157.08M |
| 299 | NAGE | Niagen Bioscience, Inc. | 244.22M | 0.98% | 555,076 | 129.08M |
| 300 | ALEC | Alector, Inc. | 233.36M | 23.67% | 5,543,326 | 13.86M |
| 301 | TARA | Protara Therapeutics, Inc. | 231.06M | -4.87% | 618,115 | - |
| 302 | SION | Sionna Therapeutics, Inc. | 230.58M | 13.33% | 14,931,116 | - |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 228.25M | 0.32% | 107,306 | - |
| 304 | CAPR | Capricor Therapeutics, Inc. | 227.59M | 2.08% | 3,331,705 | 11.13M |
| 305 | CGEN | Compugen Ltd. | 227.34M | 2.56% | 297,200 | 74.00M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 216.53M | -1.18% | 62,364 | 3.93M |
| 307 | ARCT | Arcturus Therapeutics Holdings Inc. | 213.74M | 6.67% | 821,804 | 29.37M |
| 308 | NBP | NovaBridge Biosciences | 212.79M | 3.95% | 318,920 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.64M | -1.99% | 497,172 | 29.10M |
| 310 | ANTX | AN2 Therapeutics, Inc. | 211.41M | -0.68% | 68,726 | - |
| 311 | OTLK | Outlook Therapeutics, Inc. | 211.31M | -1.74% | 6,090,376 | 333.14K |
| 312 | KROS | Keros Therapeutics, Inc. | 210.96M | -0.47% | 137,924 | 15.01M |
| 313 | IMUX | Immunic, Inc. | 210.86M | 9.79% | 169,839 | - |
| 314 | CLLS | Cellectis S.A. | 210.39M | 4.71% | 17,130 | 63.82M |
| 315 | RNA | Atrium Therapeutics, Inc. | 209.89M | 0.25% | 84,252 | 36.68M |
| 316 | DTIL | Precision BioSciences, Inc. | 207.29M | 0.67% | 345,174 | 45.06M |
| 317 | NERV | Minerva Neurosciences, Inc. | 206.27M | -6.49% | 82,232 | - |
| 318 | GALT | Galectin Therapeutics Inc. | 206.13M | 0.32% | 296,151 | - |
| 319 | IPHA | Innate Pharma S.A. | 205.92M | -3.15% | 446,071 | 10.57M |
| 320 | IVVD | Invivyd, Inc. | 202.54M | 2.14% | 1,463,594 | 55.87M |
| 321 | PEPG | PepGen Inc. | 200.85M | -3.01% | 1,145,192 | - |
| 322 | CNXU | Conexeu Sciences Inc. | 199.08M | 2.34% | 104,840 | - |
| 323 | VYGR | Voyager Therapeutics, Inc. | 197.18M | 0.95% | 397,997 | 34.46M |
| 324 | KRRO | Korro Bio, Inc. | 196.15M | -1.26% | 109,843 | 2.38M |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 195.79M | -2.02% | 373,853 | 80.62M |
| 326 | ACOG | Alpha Cognition Inc. | 193.46M | -0.06% | 56,741 | 10.83M |
| 327 | YDES | YD Bio Limited | 191.97M | 8.98% | 21,091 | 510.36K |
| 328 | HUMA | Humacyte, Inc. | 191.44M | -4.63% | 3,594,560 | 2.02M |
| 329 | CHRS | Coherus Oncology, Inc. | 186.95M | -2.42% | 968,345 | 50.94M |
| 330 | NGEN | NervGen Pharma Corp. | 185.16M | 2.35% | 202,208 | - |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 183.94M | 0.53% | 423,616 | - |
| 332 | PYXS | Pyxis Oncology, Inc. | 179.30M | -26.11% | 12,116,475 | 13.86M |
| 333 | MDWD | MediWound Ltd. | 179.03M | 0.72% | 38,994 | 14.48M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 178.40M | 1.65% | 204,689 | - |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 176.79M | 1.19% | 164,149 | 2.00M |
| 336 | MIST | Milestone Pharmaceuticals Inc. | 172.78M | 0.79% | 1,383,799 | 1.78M |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 168.46M | 1.89% | 2,023,607 | 1.34M |
| 338 | CRBU | Caribou Biosciences, Inc. | 167.62M | 1.81% | 995,208 | 11.20M |
| 339 | NKTX | Nkarta, Inc. | 166.89M | -5.28% | 593,932 | - |
| 340 | OKUR | OnKure Therapeutics, Inc. | 165.63M | 0.74% | 83,394 | - |
| 341 | LENZ | LENZ Therapeutics, Inc. | 163.36M | -2.80% | 530,037 | 21.48M |
| 342 | CDXS | Codexis, Inc. | 159.19M | -1.33% | 919,985 | 77.68M |
| 343 | KZIA | Kazia Therapeutics Limited | 158.61M | -0.50% | 95,206 | 1.27M |
| 344 | AARD | Aardvark Therapeutics, Inc. | 156.86M | -4.89% | 177,814 | - |
| 345 | ARMP | Armata Pharmaceuticals, Inc. | 156.02M | -7.61% | 231,122 | 5.20M |
| 346 | MENS | Jyong Biotech Ltd. | 155.89M | - | 35,259 | - |
| 347 | MOLN | Molecular Partners AG | 151.66M | 1.69% | - | 856.30K |
| 348 | CNTN | Canton Strategic Holdings, Inc. | 146.53M | 1.60% | 378,180 | - |
| 349 | HURA | TuHURA Biosciences, Inc. | 146.47M | 6.98% | 676,924 | - |
| 350 | CBUS | Cibus, Inc. | 145.03M | -0.52% | 157,133 | 4.29M |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 142.50M | 1.49% | 1,166,960 | 2.29M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 141.04M | 4.19% | 315,525 | 233.00K |
| 353 | EQ | Equillium, Inc. | 141.00M | 1.83% | 1,135,979 | 4.39M |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 136.97M | -0.40% | 448,439 | - |
| 355 | INDP | Indaptus Therapeutics, Inc. | 134.76M | - | 41,302 | - |
| 356 | PMN | ProMIS Neurosciences, Inc. | 134.25M | 1.70% | 32,685 | - |
| 357 | TLSA | Tiziana Life Sciences Ltd | 130.60M | - | 414,692 | - |
| 358 | SPRB | Spruce Biosciences, Inc. | 127.73M | 0.45% | 24,252 | 697.00K |
| 359 | ENGN | enGene Therapeutics Inc. | 121.92M | 4.00% | 1,446,101 | - |
| 360 | YARW | Yarrow Bioscience, Inc. | 120.23M | 2.31% | 5,428 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 120.08M | 5.56% | 812,736 | 70.00M |
| 362 | VANI | Vivani Medical, Inc. | 119.87M | -1.42% | 54,570 | - |
| 363 | SEER | Seer, Inc. | 119.48M | - | 203,141 | 14.22M |
| 364 | CUE | Cue Biopharma, Inc. | 118.62M | 8.20% | 454,620 | 32.73M |
| 365 | GNLX | Genelux Corporation | 117.68M | -2.57% | 315,951 | 8.00K |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 113.36M | 2.98% | 328,138 | 190.00K |
| 367 | NTHI | NeOnc Technologies Holdings, Inc. | 112.81M | 24.29% | 1,068,162 | 39.99K |
| 368 | COYA | Coya Therapeutics, Inc. | 112.59M | 3.45% | 130,176 | 8.02M |
| 369 | GUTS | Fractyl Health, Inc. | 111.34M | 3.97% | 1,622,423 | 3.00K |
| 370 | ANIX | Anixa Biosciences, Inc. | 109.55M | -0.92% | 135,989 | - |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 107.04M | 1.04% | 323,563 | 3.17M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 104.16M | 3.77% | 53,060 | - |
| 373 | PTHS | Pelthos Therapeutics Inc. | 99.51M | -1.28% | 37,823 | 27.70M |
| 374 | ICCC | ImmuCell Corporation | 99.06M | -0.18% | 14,490 | 29.93M |
| 375 | ONCY | Oncolytics Biotech Inc. | 97.87M | 2.14% | 672,968 | - |
| 376 | KLRS | Kalaris Therapeutics, Inc. | 94.46M | 0.76% | 27,605 | - |
| 377 | BMEA | Biomea Fusion, Inc. | 93.50M | 1.57% | 520,581 | - |
| 378 | TENX | Tenax Therapeutics, Inc. | 92.80M | 17.82% | 32,913,532 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 91.29M | -2.86% | 713,519 | - |
| 380 | ALDX | Aldeyra Therapeutics, Inc. | 91.09M | - | 473,993 | - |
| 381 | PYPD | PolyPid Ltd. | 90.69M | -0.84% | 84,216 | - |
| 382 | VRCA | Verrica Pharmaceuticals Inc. | 89.67M | 1.95% | 82,247 | 30.32M |
| 383 | GOSS | Gossamer Bio, Inc. | 88.87M | 3.24% | 10,608,452 | 55.54M |
| 384 | ACET | Adicet Bio, Inc. | 88.59M | 1.48% | 65,757 | - |
| 385 | GANX | Gain Therapeutics, Inc. | 87.87M | 16.38% | 1,673,835 | - |
| 386 | RLYB | Rallybio Corporation | 86.99M | -1.38% | 8,781 | 646.00K |
| 387 | FBIO | Fortress Biotech, Inc. | 86.70M | -5.09% | 617,237 | 66.16M |
| 388 | INO | Inovio Pharmaceuticals, Inc. | 83.96M | 3.99% | 4,419,437 | 65.34K |
| 389 | MAIA | MAIA Biotechnology, Inc. | 83.91M | -2.13% | 276,271 | - |
| 390 | ATHE | Alterity Therapeutics Limited | 82.92M | 3.41% | 6,048 | 4.43M |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 80.55M | 3.83% | 29,246 | 23.14M |
| 392 | ANVS | Annovis Bio, Inc. | 80.40M | - | 351,676 | - |
| 393 | OKYO | OKYO Pharma Limited | 79.77M | -3.18% | 57,033 | - |
| 394 | NRXS | NeurAxis, Inc. | 78.64M | -7.57% | 395,145 | 5.32M |
| 395 | TELO | Telomir Pharmaceuticals, Inc. | 77.72M | -3.42% | 27,578 | - |
| 396 | ELOX | Eloxx Pharmaceuticals, Inc. | 77.42M | 12.82% | 51,272 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 74.05M | -0.57% | 164,451 | - |
| 398 | IBIO | iBio, Inc. | 73.03M | 5.00% | 375,066 | 300.00K |
| 399 | CRDF | Cardiff Oncology, Inc. | 71.79M | 1.94% | 826,911 | 508.00K |
| 400 | LONA | LeonaBio, Inc. | 71.58M | 1.60% | 10,670 | - |
| 401 | OSTX | OS Therapies Incorporated | 71.26M | -1.84% | 132,982 | - |
| 402 | SPRO | Spero Therapeutics, Inc. | 71.22M | - | 364,060 | 61.19M |
| 403 | ELTX | Elicio Therapeutics, Inc. | 71.06M | -2.26% | 157,119 | - |
| 404 | XBIT | XBiotech Inc. | 71.04M | 2.19% | 22,448 | - |
| 405 | CING | Cingulate Inc. | 70.04M | -0.95% | 91,286 | - |
| 406 | RNTX | Rein Therapeutics Inc. | 69.88M | 2.88% | 201,420 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 69.33M | 5.69% | 314,870 | - |
| 408 | CSBR | Champions Oncology, Inc. | 69.33M | -2.92% | 16,141 | 59.43M |
| 409 | ALPS | Alps Group Inc | 67.39M | -2.88% | 132,796 | 3.74M |
| 410 | MNOV | MediciNova, Inc. | 64.97M | - | 17,734 | 596.64K |
| 411 | HYFT | MindWalk Holdings Corp. | 64.84M | 1.47% | 56,564 | 11.43M |
| 412 | BSEM | BioStem Technologies, Inc. | 63.99M | -4.50% | 41,653 | 37.65M |
| 413 | PLRX | Pliant Therapeutics, Inc. | 63.78M | -0.96% | 220,282 | - |
| 414 | IMA | ImageneBio, Inc. | 63.68M | -1.92% | 3,113 | 800.00K |
| 415 | DWTX | Dogwood Therapeutics, Inc. | 61.88M | 0.55% | 52,543 | - |
| 416 | BOLD | Boundless Bio, Inc. | 61.77M | -2.48% | 297,491 | - |
| 417 | HRTX | Heron Therapeutics, Inc. | 61.47M | -3.34% | 9,770,246 | 151.18M |
| 418 | INMB | INmune Bio Inc. | 57.73M | -1.89% | 436,626 | 50.00K |
| 419 | INKT | MiNK Therapeutics, Inc. | 55.95M | 2.56% | 5,918 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 54.92M | -0.22% | 6,186 | 53.48M |
| 421 | EDSA | Edesa Biotech, Inc. | 53.18M | 5.34% | 34,111 | - |
| 422 | IMMP | Immutep Limited | 53.06M | 2.40% | 59,427 | 5.28M |
| 423 | EXOZ | eXoZymes, Inc. | 52.48M | 10.77% | 4,331 | -700.00 |
| 424 | ATYR | aTyr Pharma, Inc. | 52.36M | 0.96% | 495,317 | 190.00K |
| 425 | RNXT | RenovoRx, Inc. | 51.86M | -0.86% | 361,521 | 1.49M |
| 426 | TIL | Instil Bio, Inc. | 50.80M | 1.08% | 6,982 | - |
| 427 | TCRX | TScan Therapeutics, Inc. | 50.76M | 1.28% | 248,094 | 9.14M |
| 428 | MREO | Mereo BioPharma Group plc | 48.76M | 12.15% | 163,833,119 | 500.00K |
| 429 | VRXA | Veraxa Biotech AG | 47.66M | 2.16% | 41,080 | - |
| 430 | KPTI | Karyopharm Therapeutics Inc. | 47.59M | 7.14% | 1,962,555 | 151.12M |
| 431 | FLNA | Filana Therapeutics, Inc. | 46.94M | -2.58% | 276,093 | - |
| 432 | IBO | Impact BioMedical Inc. | 46.36M | -1.26% | 81,672 | 35.00K |
| 433 | MCRB | Seres Therapeutics, Inc. | 46.13M | -7.20% | 84,677 | 1.88M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | -1.63% | 133,112 | 13.56M |
| 435 | ALGS | Aligos Therapeutics, Inc. | 45.46M | -4.84% | 237,714 | 31.52M |
| 436 | VERU | Veru Inc. | 44.78M | 0.72% | 456,632 | 16.89M |
| 437 | GRCE | Grace Therapeutics, Inc. | 44.60M | 0.47% | 97,764 | - |
| 438 | CNTX | Context Therapeutics Inc. | 42.80M | 2.98% | 1,222,251 | - |
| 439 | CRVO | CervoMed Inc. | 41.80M | 8.04% | 791,272 | 331.30K |
| 440 | SER | Serina Therapeutics, Inc. | 41.69M | 4.12% | 118,072 | 130.00K |
| 441 | HYPD | Hyperion DeFi, Inc. | 40.02M | 1.15% | 121,944 | 1.04M |
| 442 | APLM | Apollomics, Inc. | 39.88M | 1.74% | 1,766 | 8.84M |
| 443 | RADX | Radiopharm Theranostics Limited | 39.81M | 2.14% | 29,476 | 10.86M |
| 444 | NTRB | Nutriband Inc. | 38.66M | 1.27% | 8,032 | 1.80M |
| 445 | DYAI | Dyadic International, Inc. | 38.26M | 5.51% | 203,669 | 3.81M |
| 446 | LTRN | Lantern Pharma Inc. | 35.47M | -1.07% | 50,889 | - |
| 447 | BYSI | BeyondSpring Inc. | 32.48M | 0.54% | 11,002 | 1.88M |
| 448 | QNCX | Quince Therapeutics, Inc. | 32.01M | 6.79% | 35,224 | - |
| 449 | NNVC | NanoViricides, Inc. | 30.98M | -2.86% | 249,608 | - |
| 450 | ENLV | Enlivex Ltd. | 30.85M | -4.48% | 185,624 | - |
| 451 | GNTA | Genenta Science S.p.A. | 30.67M | - | 32,388 | - |
| 452 | LITS | Lite Strategy, Inc. | 30.66M | 3.57% | 74,082 | - |
| 453 | ESLA | Estrella Immunopharma, Inc. | 30.34M | -2.34% | 13,307 | - |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.85M | 1.77% | 62,556 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 28.62M | 1.43% | 13,018 | 7.44M |
| 456 | IGC | IGC Pharma, Inc. | 28.13M | 5.05% | 2,634,821 | 1.11M |
| 457 | TVGN | Tevogen Inc. | 28.06M | 4.07% | 6,862 | - |
| 458 | CVM | CEL-SCI Corporation | 26.57M | 2.01% | 103,760 | - |
| 459 | CNSY | Cerenome, Inc. | 26.36M | -0.26% | 62,769 | 5.18M |
| 460 | EVAX | Evaxion A/S | 25.52M | 0.33% | 17,109 | 7.53M |
| 461 | JSPR | Jasper Therapeutics, Inc. | 25.02M | 11.72% | 1,433,713 | - |
| 462 | ABVC | ABVC BioPharma, Inc. | 24.89M | 3.67% | 123,037 | 797.92K |
| 463 | ATNM | Actinium Pharmaceuticals, Inc. | 24.88M | 2.97% | 168,769 | 35.09M |
| 464 | NXTC | NextCure, Inc. | 24.31M | -1.61% | 181,444 | - |
| 465 | ACTU | Actuate Therapeutics, Inc. | 24.17M | -0.98% | 316,158 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 23.50M | 2.34% | 8,226 | 14.97M |
| 467 | QNTM | Quantum BioPharma Ltd. | 22.97M | 2.60% | 475,004 | - |
| 468 | ALLR | Allarity Therapeutics, Inc. | 22.75M | 1.42% | 133,754 | 345.00K |
| 469 | GRDX | GridAI Technologies Corp. | 22.31M | 4.65% | 157,546 | - |
| 470 | LGVN | Longeveron Inc. | 21.87M | -6.00% | 914,071 | 1.22M |
| 471 | DARE | Daré Bioscience, Inc. | 21.57M | 5.88% | 141,983 | 1.16M |
| 472 | CLRB | Cellectar Biosciences, Inc. | 21.10M | 1.54% | 20,552 | - |
| 473 | COCP | Cocrystal Pharma, Inc. | 20.80M | - | 75,482 | 225.00K |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 20.59M | -1.30% | 30,362 | -13.27K |
| 475 | ATOS | Atossa Therapeutics, Inc. | 20.32M | -0.42% | 56,705 | - |
| 476 | CELU | Celularity Inc. | 20.27M | 1.98% | 30,129 | 26.55M |
| 477 | CTXR | Citius Pharmaceuticals, Inc. | 19.77M | 6.35% | 362,479 | 5.61M |
| 478 | PLRZ | Polyrizon Ltd. | 19.07M | -10.06% | 45,319 | - |
| 479 | SKYE | Skye Bioscience, Inc. | 19.01M | 1.58% | 102,875 | - |
| 480 | PLUR | Pluri Inc. | 18.88M | -4.89% | 10,959 | 1.08M |
| 481 | TPST | Tempest Therapeutics, Inc. | 18.86M | 13.46% | 1,775,948 | - |
| 482 | MRKR | Marker Therapeutics, Inc. | 18.67M | -2.61% | 55,615 | 3.55M |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 18.65M | 0.45% | 146,143 | 21.00M |
| 484 | LPCN | Lipocine Inc. | 17.23M | -0.48% | 13,317 | 1.57M |
| 485 | NCEL | NewcelX Ltd. | 17.17M | -1.85% | 17,802 | - |
| 486 | NRSN | NeuroSense Therapeutics Ltd. | 16.77M | -2.02% | 144,425 | - |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 16.60M | 0.57% | 183,768 | - |
| 488 | CYCN | Cyclerion Therapeutics, Inc. | 16.45M | -0.28% | 10,605 | 1.90M |
| 489 | KTTA | Pasithea Therapeutics Corp. | 15.94M | 0.65% | 73,453 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.79M | 1.81% | 9,078 | 152.72K |
| 491 | KALA | KALA BIO, Inc. | 15.71M | 11.91% | 81,121 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 14.84M | - | 98,838 | 1.44M |
| 493 | MLEC | Moolec Science SA | 14.73M | 1.00% | 3,722 | 7.83M |
| 494 | PASG | Passage Bio, Inc. | 14.44M | 4.17% | 3,704 | - |
| 495 | PDSB | PDS Biotechnology Corporation | 14.33M | -64.87% | 28,273,577 | - |
| 496 | CMMB | Chemomab Therapeutics Ltd. | 13.68M | 0.53% | 18,122 | - |
| 497 | OSRH | OSR Health, Inc. | 13.55M | -5.99% | 688,310 | 2.63M |
| 498 | AKTX | Akari Therapeutics, Plc | 13.53M | 2.66% | 11,444 | - |
| 499 | BLRX | BioLineRx Ltd. | 13.12M | 2.32% | 4,591 | 1.40M |
| 500 | PTN | Palatin Technologies, Inc. | 13.10M | 0.68% | 6,924 | 12.88M |